Gene and Stem Cell Therapies for Treating Epilepsy
نویسندگان
چکیده
Introduction .................................................................................................................................... 583 Background .................................................................................................................................... 584 Gene Therapy for Temporal Lobe Epilepsy ................................................................................... 586 GABAA Receptors and GABA .................................................................................................. 587 Neuropeptide Y ......................................................................................................................... 588 Galanin ...................................................................................................................................... 588 Glial Cell-Derived Neurotrophic Factor.................................................................................... 589 Gene Therapy for Neuroprotection ........................................................................................... 589 Prospects for Treating Genetic Forms of Epilepsy with Gene Therapy .................................... 589 Stem Cell Therapy for Temporal Lobe Epilepsy ........................................................................... 590 The GABA Hypothesis of TLE ................................................................................................. 590 Studies of Fetal Neurons as a Source for Transplantation ........................................................ 591 Genetically Engineered Cell Lines as a Source for Transplantation ......................................... 592 Neuromodulation with Adenosine............................................................................................. 592 ES Cell-Derived Neurons for Cell Transplantation Therapies .................................................. 593 Generating Specific Types of Neurons for Transplantation from ES Cells ............................... 593 Role of Epigenetic Factors in Regulating the Production and Differentiation of ES CellDerived Neural Precursors for Transplantation ......................................................................... 594 Conclusions .................................................................................................................................... 596 Acknowledgments .......................................................................................................................... 596 References ...................................................................................................................................... 596
منابع مشابه
P 111: Use of Stem Cell Therapy for Treatment of Temporal Lobe Epilepsy (TLE)
Epilepsy is one of the most common neuroinflammatory disorders that affect more than 50 million people worldwide. Excessive electrical discharges in neurons following neural cell damage or loss leads to recurrent seizures, which are described as epilepsy. One of the most common and difficult to treat types of epilepsy is Temporal Lobe Epilepsy (TLE), which results from hippocampal sclerosis. Cu...
متن کاملCell based therapies in retinal diseases
Background Degenerative retinal diseases, including age related macular degeneration, glaucoma, and hereditary retinal dystrophies are major causes of blindness. The principal defect in these diseases is cell loss which is amenable to both cell based neuroprotective and neuroregenerative therapies. To briefly review the lines of research and potential candidates for cell based therapies among ...
متن کاملP 89: Reduction of Neuroinflammation in Epilepsy by Using Stem Cells Derived Astrocytes
Epilepsy is neurological disorders that afflict many people around the world with a higher prevalence rate in children and in low income countries. Temporal lobe epilepsy (TLE) is result from hippocampal sclerosis is a neurological disorder with difficult treatment. Stem cells can transform into any type of cells such as glial cells, consequently stem cells can use for medical treatment. Stem c...
متن کاملکاربرد سلول های بنیادی در درمان بیماری پارکینسون
Stem cells are undifferentiated cells with the ability to divide and differentiate into distinct cell types. The source of these cells is from embryos and adults, that each cell has its own specific characteristics. For nearly decades, experimental studies have been conducted to use these types of cells to treat various diseases. Parkinson's disease is one of the most common neurodegenerative d...
متن کاملAfter introduction of advanced therapeutic medicinal products (ATMPs) in Ischemic Stroke; novel therapeutic modalities from financial perspective
Stroke, is accounting for more than 34% of total healthcare spending globally. Ischemic stroke (IS) accounts for 62.4% of incident stroke cases. IS-related direct medical expenditures place a considerable burden on healthcare system. The burden is more prominent in developing countries where limitations in insurance coverage is a big concern. It would be less challenging in developed countries,...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2010